60 results
Page 3 of 3
S-3
tdzevn591xeromsd frd
20 Dec 19
Shelf registration
4:17pm
S-3
EX-1.1
9zad8bp7
20 Dec 19
Shelf registration
4:17pm
8-K
EX-99.2
dq77i2cf40kni1z3 ep
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
fcg4y
9 May 19
Quarterly report
7:13am
10-K
EX-10.6
7974sky
28 Feb 19
Annual report
1:08pm
10-K
EX-10.12
o90460ugz duop306yw
28 Feb 19
Annual report
1:08pm
10-K
hqv4y0gu8w hsj
28 Feb 19
Annual report
1:08pm
424B5
rs1tr5hu9uc6jdl
25 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-1.1
hb70q9tyuu62 315r5
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
424B5
noceac6c2f cpku
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
gyho8vr5m rqq
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
6-K
EX-99.1
13fvgqsn8a
13 Nov 18
Current report (foreign)
6:33am
F-3
EX-1.2
8wjhnu
12 Oct 18
Shelf registration (foreign)
5:24pm
6-K
EX-99.1
s2ryfb
14 Aug 18
Current report (foreign)
4:09pm
6-K
EX-99.1
ygnhdhi 9q
15 May 18
Current report (foreign)
4:24pm
20-F
pri0bkk
15 Mar 18
Annual report (foreign)
12:00am
424B4
xefr7
22 Jan 18
Prospectus supplement with pricing info
12:00am